Clinical Trial Update: A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus [NA]

View source ↗

Summary

This update reports on a completed clinical trial evaluating zidovudine (AZT) for preventing HIV infection in individuals exposed to the virus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | NA | Status: COMPLETED